Fulton Bank’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,682
Closed -$202K 584
2023
Q1
$202K Buy
+5,682
New +$206K 0.01% 532
2022
Q3
Sell
-3,168
Closed -$227K 506
2022
Q2
$227K Buy
3,168
+299
+10% +$21.9K 0.01% 439
2022
Q1
$232K Sell
2,869
-402
-12% -$34K 0.01% 473
2021
Q4
$336K Buy
3,271
+194
+6% +$18.6K 0.01% 413
2021
Q3
$270K Buy
3,077
+36
+1% +$3.26K 0.01% 442
2021
Q2
$272K Buy
3,041
+92
+3% +$7.77K 0.01% 424
2021
Q1
$224K Buy
+2,949
New +$222K 0.01% 442

Other funds holding SYNH

Fulton Bank's SYNH Position: Q2 2023 in Review

Fulton Bank sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 5,682 shares — an estimated $202K sold.

Fulton Bank first reported a position in SYNH in Q1 2021 and held it in 7 quarters. The position peaked at $336K in Q4 2021. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Fulton Bank reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Fulton Bank sold 5,682 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $202K.
  • Fulton Bank first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2021 and held it in 7 quarters.
  • Fulton Bank's Syneos Health, Inc. Class A Common Stock position peaked at $336K in Q4 2021.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Fulton Bank's 13F filing for Q2 2023, filed 6 Jul 2023.